Efficacy and safety of fumaric acid esters in young patients aged 10–17 years with moderate‐to‐severe plaque psoriasis: a randomized, double‐blinded, placebo‐controlled trial

Hamm, H.; Wilsmann‐Theis, D.; Tsianakas, A.; Gambichler, T.; Taipale, K.; Lauterbach, J.; Freudensprung, U.; Makepeace, C.; Bonnekoh, B.; Dirschka, T.; Gerdes, S.; Ghoreschi, K.; Wozel, G.; von Kiedrowski, R.; Körber, A.; Philipp, S.; Schäkel, K.; Schnopp, C.; Reich, K.; Staubach-Renz, P.; Maniu, C.-M.; Stavermann, T.; Effendy, Isaak; Leitz, N.; Kleinheinz, A.; Rotterdam, S.

Efficacy and safety of fumaric acid esters in young patients aged 10–17 years with moderate‐to‐severe plaque psoriasis: a randomized, double‐blinded, placebo‐controlled trial

Hamm H, Wilsmann‐Theis D, Tsianakas A, Gambichler T, Taipale K, Lauterbach J, Freudensprung U, Makepeace C, Bonnekoh B, Dirschka T, Gerdes S, et al. (2021)
British Journal of Dermatology 185(1): 62-73.

Zeitschriftenaufsatz | Veröffentlicht | Englisch

Download

bjd0062.pdf 1.95 MB

URL

https://academic.oup.com/bjd/article/185/1/62/6600399

DOI

https://doi.org/10.1111/bjd.19747

URN

urn:nbn:de:0070-pub-29695001

Autor*in

Hamm, H.; Wilsmann‐Theis, D.; Tsianakas, A.; Gambichler, T.; Taipale, K.; Lauterbach, J.; Freudensprung, U.; Makepeace, C.; Bonnekoh, B.; Dirschka, T.; Gerdes, S.; Ghoreschi, K.
Alle

Einrichtung

Medizinische Fakultät OWL > Vertretungsprofessur für Dermatologie

Erscheinungsjahr

2021

Zeitschriftentitel

British Journal of Dermatology

Band

185

Ausgabe

1

Seite(n)

62-73

Urheberrecht / Lizenzen

Creative Commons Namensnennung 4.0 International Public License (CC-BY 4.0)

ISSN

0007-0963

eISSN

1365-2133

Page URI

https://pub.uni-bielefeld.de/record/2969500

Zitieren

Hamm H, Wilsmann‐Theis D, Tsianakas A, et al. Efficacy and safety of fumaric acid esters in young patients aged 10–17 years with moderate‐to‐severe plaque psoriasis: a randomized, double‐blinded, placebo‐controlled trial. British Journal of Dermatology. 2021;185(1):62-73.

Hamm, H., Wilsmann‐Theis, D., Tsianakas, A., Gambichler, T., Taipale, K., Lauterbach, J., Freudensprung, U., et al. (2021). Efficacy and safety of fumaric acid esters in young patients aged 10–17 years with moderate‐to‐severe plaque psoriasis: a randomized, double‐blinded, placebo‐controlled trial. British Journal of Dermatology, 185(1), 62-73. https://doi.org/10.1111/bjd.19747

Hamm, H., Wilsmann‐Theis, D., Tsianakas, A., Gambichler, T., Taipale, K., Lauterbach, J., Freudensprung, U., et al. 2021. “Efficacy and safety of fumaric acid esters in young patients aged 10–17 years with moderate‐to‐severe plaque psoriasis: a randomized, double‐blinded, placebo‐controlled trial”. British Journal of Dermatology 185 (1): 62-73.

Hamm, H., Wilsmann‐Theis, D., Tsianakas, A., Gambichler, T., Taipale, K., Lauterbach, J., Freudensprung, U., Makepeace, C., Bonnekoh, B., Dirschka, T., et al. (2021). Efficacy and safety of fumaric acid esters in young patients aged 10–17 years with moderate‐to‐severe plaque psoriasis: a randomized, double‐blinded, placebo‐controlled trial. British Journal of Dermatology 185, 62-73.

Hamm, H., et al., 2021. Efficacy and safety of fumaric acid esters in young patients aged 10–17 years with moderate‐to‐severe plaque psoriasis: a randomized, double‐blinded, placebo‐controlled trial. British Journal of Dermatology, 185(1), p 62-73.

H. Hamm, et al., “Efficacy and safety of fumaric acid esters in young patients aged 10–17 years with moderate‐to‐severe plaque psoriasis: a randomized, double‐blinded, placebo‐controlled trial”, British Journal of Dermatology, vol. 185, 2021, pp. 62-73.

Hamm, H., Wilsmann‐Theis, D., Tsianakas, A., Gambichler, T., Taipale, K., Lauterbach, J., Freudensprung, U., Makepeace, C., Bonnekoh, B., Dirschka, T., Gerdes, S., Ghoreschi, K., Wozel, G., von Kiedrowski, R., Körber, A., Philipp, S., Schäkel, K., Schnopp, C., Reich, K., Staubach-Renz, P., Maniu, C.-M., Stavermann, T., Effendy, I., Leitz, N., Kleinheinz, A., Rotterdam, S.: Efficacy and safety of fumaric acid esters in young patients aged 10–17 years with moderate‐to‐severe plaque psoriasis: a randomized, double‐blinded, placebo‐controlled trial. British Journal of Dermatology. 185, 62-73 (2021).

Hamm, H., Wilsmann‐Theis, D., Tsianakas, A., Gambichler, T., Taipale, K., Lauterbach, J., Freudensprung, U., Makepeace, C., Bonnekoh, B., Dirschka, T., Gerdes, S., Ghoreschi, K., Wozel, G., von Kiedrowski, R., Körber, A., Philipp, S., Schäkel, K., Schnopp, C., Reich, K., Staubach-Renz, P., Maniu, C.-M., Stavermann, T., Effendy, Isaak, Leitz, N., Kleinheinz, A., and Rotterdam, S. “Efficacy and safety of fumaric acid esters in young patients aged 10–17 years with moderate‐to‐severe plaque psoriasis: a randomized, double‐blinded, placebo‐controlled trial”. British Journal of Dermatology 185.1 (2021): 62-73.

Alle Dateien verfügbar unter der/den folgenden Lizenz(en):

Creative Commons Namensnennung 4.0 International Public License (CC-BY 4.0):